You are here

NS5A Inhibitors

J&J snaps up an NS5A inhibitor from GlaxoSmithKline for hep C cocktail

Fierce Biotech

Tue, 10/8/13 - 09:41 am

NS5A Inhibitors

Why A Change In A Bristol-Myers Hepatitis C Trial Has Big Implications

Forbes

Fri, 06/29/12 - 09:25 am

Bristol-Myers Squibb

NS5A Inhibitors

Bristol Hep C Trial Change Has Big Implications

Pharmalot

Wed, 06/20/12 - 12:31 pm

Bristol-Myers Squibb

clinical trials

NS5A Inhibitors

Presidio Pharmaceuticals, Inc. Announces Clinical Proof-of-Concept Data for its First HCV NS5A Inhibitor, PPI-461, and Initiation of Clinical Testing for its Second-Generation NS5A Inhibitor, PPI-668.

BusinessWire

Sun, 11/6/11 - 12:19 pm

NS5A Inhibitors